We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Portable Device to Quickly Detect Bacterial Pathogens Using New Optical Signature

By LabMedica International staff writers
Posted on 28 Aug 2023
Print article
Image: Dynabeads (grey spheres) interacting with Salmonella bacterium (in green) (Photo courtesy of MIT)
Image: Dynabeads (grey spheres) interacting with Salmonella bacterium (in green) (Photo courtesy of MIT)

Receiving results from a blood test or other diagnostic assessments often involves a waiting period of one to seven days, depending on the specific test's target. This time lag can be primarily attributed to the laborious steps in sample processing and analysis. The quantities of diseased cells or pathogens in fluid samples are so minute that they require cultivation in controlled settings to increase their numbers. Subsequently, these cultures are stained and examined under a microscope. This comprehensive procedure extends over several days to yield a conclusive positive or negative outcome. Now, researchers have identified a new optical signature in a commonly used class of magnetic beads, known as Dynabeads. This discovery holds the potential to speed up the detection of contaminants in various diagnostic tests, such as identifying traces of the foodborne pathogen Salmonella.

Dynabeads, microscopic magnetic beads, are capable of being coated with antibodies that attach to specific target molecules, like pathogens. Typically, Dynabeads are integrated into solutions to capture desired molecules, but further time-consuming steps are essential to confirm their presence and attachment to the beads. A team of scientists at Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) have leveraged optics, specifically Raman spectroscopy, to confirm the presence of Dynabead-bound pathogens. Raman spectroscopy is an optical technique for identifying specific molecules through the unique way in which a molecule scatters light, referred to as their "Raman signature." The researchers discovered that Dynabeads exhibit an unusually strong Raman signature, similar to a fluorescent tag, enabling rapid detection with this distinctive signature functioning as a "reporter." Detecting this signal quickly can confirm the existence of a target pathogen in a given sample within less than a second.

In a practical demonstration, the researchers mixed Dynabeads into vials containing Salmonella-contaminated water. These beads were magnetically isolated onto microscope slides, after which the researchers measured how light scattered through the fluid upon exposure to laser light. Within just half a second, the Dynabeads' Raman signature was detected, confirming the presence of bound Dynabeads and, consequently, Salmonella in the fluid. This novel technique surpasses conventional methods in speed and incorporates components that could be adapted into more compact, portable formats. The team is actively working on devising a portable device capable of rapidly detecting an array of bacterial pathogens. In particular, the researchers aim to apply this approach to critical conditions such as sepsis, where prompt pathogen detection is vital and existing lab tests may not rapidly fulfill this requirement.

“This technique would be useful in a situation where a doctor is trying to narrow down the source of an infection in order to better inform antibiotic prescription, as well as for the detection of known pathogens in food and water,” said study co-author Marissa McDonald, a graduate student in the Harvard-MIT Program in Health Sciences and Technology. “Additionally, we hope this approach will eventually lead to expanded access to advanced diagnostics in resource-limited environments.”

“There are a lot of cases, like in sepsis, where pathogenic cells cannot always be grown on a plate,” said Jongwan Lee, MIT Postdoctoral Associate and study co-author. “In that case, our technique could rapidly detect these pathogens.”

Related Links:
MIT 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.